Spinal cord contusion causes acute plasma membrane damage.
Spinal cord injury (SCI) launches a complex cascade of events that leads to progressive damage and loss of function. Compromise of plasma membrane integrity due to the mechanical impact is an acute event that may contribute to cellular dysfunction. Therefore, the objective of this study was to better understand the extent of acute plasma membrane damage associated with SCI as a function of injury severity and membrane defect size. Fluorescent cell-impermeant dyes were injected into the cerebrospinal fluid of adult male rats prior to contusion injury, and the anatomical location of cell bodies and axons taking up the dye within 10 min following SCI was quantified. Lucifer yellow uptake was assessed as a function of impact force (experimental groups: sham, 100 kdyn, 150 kdyn, and 200 kdyn force). In a separate group of animals, FITC-conjugated dextran molecules of various sizes (3 kDa and 10 kDa with a 1.6-nm and 2.7-nm radius, respectively) were used to approximate the size of membrane defects following moderate injury (150 kdyn force). Quantification revealed that cellular uptake of lucifer yellow was positively correlated with the force of the mechanical impact, indicating that the severity of injury is related to the degree of acute membrane failure. In addition, after moderate injury, cell bodies and axons (located up to 2 mm and 3 mm from the epicenter, respectively) took up significantly more of the 3-kDa and 10-kDa dextran permeability marker compared to sham controls. Permeable neuronal cell bodies exhibited a morphological appearance characterized by pericellular blebbing, suggesting that plasma membrane compromise is associated with pathophysiological cellular alterations. Collectively, these results enhance our understanding of acute SCI and provide targets for developing novel treatment strategies.
Simon
Crystal M
CM
The Wallace H. Coulter Department of Biomedical Engineering at Georgia Institute of Technology and Emory University, Laboratory for Neuroengineering, and Parker H. Petit Institute for Bioengineering and Bioscience, Atlanta, Georgia, USA.
Sharif
Shan
S
Tan
Richard P
RP
LaPlaca
Michelle C
MC
D000818:Animals; D001369:Axons / Q000473:pathology; D002462:Cell Membrane / Q000473:pathology*; D002463:Cell Membrane Permeability / Q000502:physiology; D003911:Dextrans / Q000493:pharmacokinetics; D004195:Disease Models, Animal; D016650:Fluorescein-5-isothiocyanate / Q000031:analogs & derivatives / Q000493:pharmacokinetics; D007546:Isoquinolines / Q000493:pharmacokinetics; D008297:Male; D009410:Nerve Degeneration / Q000209:etiology / Q000473:pathology* / Q000503:physiopathology; D009474:Neurons / Q000473:pathology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D013119:Spinal Cord Injuries / Q000150:complications / Q000473:pathology* / Q000503:physiopathology; D013314:Stress, Mechanical
D003911:Dextrans; D007546:Isoquinolines; C015219:fluorescein isothiocyanate dextran; C017475:lucifer yellow; D016650:Fluorescein-5-isothiocyanate